Key result
Moxonidine significantly increased normal and impaired corticocerebral blood flow while reducing mean arterial blood pressure and heart rate in conscious rabbits.
Why the study?
Does moxonidine improve corticocerebral blood flow and reduce blood pressure and heart rate in conscious rabbits under normal and ischemic conditions?
Population
Conscious rabbits under normal conditions and with unilateral carotid occlusion-induced impaired…
Design
Preclinical
Authors
Loading...
Hypothesis-generating for cerebral ischemia models; leaves open translation to human cerebrovascular disease.
Does moxonidine improve corticocerebral blood flow and reduce blood pressure and heart rate in conscious rabbits under normal and ischemic conditions?
Moxonidine reduces blood pressure and heart rate while significantly increasing corticocerebral blood flow in conscious rabbits, suggesting potential benefits in managing cerebral ischemia.
Csete et al. (2000) studied Normal and impaired corticocerebral blood flow. Moxonidine was evaluated on Corticocerebral blood flow (cCBF), mean arterial blood pressure (MABP), and heart rate (HR). Moxonidine significantly increased normal and impaired corticocerebral blood flow while reducing mean arterial blood pressure and heart rate in conscious rabbits.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: